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Abstract 
Introduction: Hyperlipidemia is a modifiable risk factor of an important killer disease “cardiovascular diseases”, 
which account for as much mortality as infectious disease, nutritional deficiency and maternal and prenatal 
disease combined together. Aim: To investigate the effect of oral administration of Aqueous-methanol stem bark 
extract of Khaya senegalensis and its solvents (hexane, chloroform and ethyl acetate) extracts on lipid profile of 
hyperlipidemic rats. Methodology: Hyperlipidemia was induced in rats via feeding on high lipid diet (HLD) for 
6 weeks. A total of fifty five (55) rats were divided into two phases: For phase one, twenty five (25) rats were 
placed into five groups (GI - GV) of five rats each. GI served as normal control, GII serves as hyperlipidemic 
control group, while GIII, GIV and GV were hyperlipidemic and administered with crude extract (E1) at a dose 
of 250mg/kg, 350mg/kg and 450mg/kg body weight respectively for two weeks. For the second phase, thirty (30) 
rats were placed into six (6) groups of five (5) rats. GI served as normal control, GII served as hyperlipidemic 
control group, while GIII, GIV GV and GVI were hyperlipidemic and administered with hexane extract (E2), 
chloroform extract (E3), ethyl acetate extract (E4) and the residue (E5) at a dose of 250mg/kg body weight 
respectively for two weeks. The animals from each group were euthanized and serum was collected for analysis 
lipid profile (Total Cholesterol, LDL-Cholesterol, HDL-Cholesterol and Triglyceride). Results: The research 
found that aqueous methanol extract of Khaya senegalensis possess hypolipidemic ability with the ethyl acetate 
extract showing the highest potency with a significant (p<0.01) decrease in serum total cholesterol, triglyceride 
and LDL-cholesterol level when compared to hyperlipidemic control. Conclusion: The present study 
demonstrated that the ethyl acetate extract from the crude extract possesses the highest hypolipidemic activity. 
Keywords: High lipid diets; hyperlipidemia; lipid profile; Khaya senegalensis; sequential extraction. 
 
1. Introduction 
Hyperlipidemia is the presence of elevated levels of lipids and/or lipoproteins fractions (LDL-cholesterol, Total 
cholesterol and Triglyceride) in the blood. Hyperlipidemia is classified into two; familial (also called primary 
hyperlipidemia) caused by specific genetic abnormalities or acquired (also called secondary hyperlipidemia) 
when resulting from another underlying disorder that lead to alterations in plasma lipids and lipoprotein 
metabolism (Chait and Brunzell, 1990). Hyperlipidemia has a diverse and complex etiology consisting of genetic, 
lifestyle, and environmental factors, It is not a disease but a metabolic derangement that can lead to many 
diseases, most notably cardiovascular diseases (Durrington, 2003). 
Significant ethnic differences exist in the prevalence and types of lipid disorders. While elevated serum 
Total-cholesterol and LDL-cholesterol are the main concern in Western populations, in other countries 
hypertriglyceridemia and low HDL-cholesterol are more prevalent (Bell et al., 1997). The escalating trend of 
obesity, as well as changes in lifestyle and environmental factors have make lipid disorders a global medical and 
public health threat (Telmo Pereira, 2012). Elevated levels of LDL-cholesterol and lower level of HDL-
Cholesterol are regarded as atherogenic (prone to cause atherosclerosis) (Lewington, 2007). This disease process 
leads to myocardial infraction, stroke and peripheral vascular diseases (Brunzell, 2008). LDL particles are often 
termed “bad cholesterol” because they have been linked to atheroma formation. On the other hand, high 
concentration of functional HDL, which can remove cholesterol from cells and atheroma, offer protection and 
are sometimes referred to colloquially as “good cholesterol”. If these postulations were correct, then lowering 
blood lipid (Total-cholesterol Triglycerides and LDL-cholesterol) concentration should reduce mortality and 
morbidity from diseases associated with high lipid concentration, most notably cardiovascular diseases. 
Khaya senegalensis A. Juss (Meliaceae) is commonly called the dry zone mahogany or African 
mahogany. The specific name means ‘of Senegal’, which is where the type specimen was collected  and regarded 
as the most popular medicinal meliaceous plant in African traditional remedies (Danquah et al.,2012). The bitter 
bark extract have been used as a folk medicine for treatment of diabetes (Kolawole et al., 2012), kidney diseases 
(El Badwi et al., 2012), jaundice (Muhammad et al., 2015) and malaria (Bickii et al., 2010). The bark extract has 
been used as an astringent for wounds and used occasionally for tanning because of the rich red color it provides. 
Roots are applied topically against stomach-ache, oedema and amenorrhoea, young twigs and roots are used as 
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chewing sticks, and Fruits extracts have been shown to exhibit Antioxidative and hypolipidemic properties 
(Ijeoma et al., 1997, Kalpana and Pugalendi, 2011). 
 
2. Materials and methods 
2.1 Study animals 
Fifty (50) male and female albino rats of three to four months weighting 80-120 g were purchased from the 
department of Biological Science, Bayero University Kano, they were housed in aluminum cages with saw dust 
at the bottom of the cage at an ambient temperature (temperature 25-30°C, photo period 12 hours natural light 
and 12 hours dark). The animals had free access to standard palletized grower feed and drinking water. The rats 
were allowed to acclimatize for one week prior to the experiment. Principle of laboratory animal care (NIH, 
1996). Ethical guidelines for investigation of experimental pain in conscious animals were observed during 
experimentation (Zimmermann, 1983). 
 
2.2 Plant material 
Khaya senegalensis stem barks were collected from Bayero University Kano (located in the ancient city of Kano, 
North West of Nigeria). The plant was identified and authenticated at the Herbarium of Plant Biology 
Department, Bayero University Kano and was given a voucher number of (BUK/HAN/0116). The stem bark was 
shade dried and ground to powder. 
 
2.3 Extract preparation 
Five hundred gram of the powder was weighed and soaked in two liters of 1:1 distilled water-methanol, the 
solution was shaken vigorously and left to stand at room temperature for 24 hours. The mixture was filtered by 
passing through Whattman’s Filter No.1. The filtrate thus obtained was concentrated by complete evaporation of 
solvent using rotary evaporator to yield the crude aqueous-methanol extract labelled E1. 
2.3.1 Fractionation of crude extract 
The solvent free aqueous-methanol crude extract (50g) was suspended in distilled water (500 mL). The 
suspension was transferred into a separatory funnel. Then it was extracted successively with equal volume of 
different organic solvent with increasing polarity viz-a-viz hexane, chloroform and ethyl acetate. The extraction 
procedure was repeated twice for all solvent for complete extraction and then filtered. The combined extracts 
were concentrated and evaporated using rotary evaporator and dried under water bath, hexane extract was 
labelled E2, chloroform extract labelled E3, ethyl acetate extract labelled E4 and the residue labelled E5. 
The volume to be administered to animals was calculated according to the method of (Muhammad and Alhassan, 
2016). 
 
2.4 Induction of hyperlipidemia 
A modified method of Vesselinvitch et al 1980 was used to induce hyperlipidemia. The rats were exposed to the 
high lipid diet formulation for a period of six weeks. The diet was formulated by mixing pure cholesterol, palm 
oil and grower mash feed in a percentage ratio of 2:20:78 by mass. 
A total of sixty (60) rats were placed into five (5) groups of twelve (12) rats each. Group one was feed 
on normal grower mash while the rest were feed on high lipid diet. Body weight gain of rats were recorded 
weekly. Segregation into hyperlipidemic induced rats was performed based on the weight gained by the rats. 
Rats with the highest body weight gain (Upper one-third, weight gained >66.67%) were considered to be 
hyperlipidemic. 
 
2.5 Experimental protocol 
The research was divided into two phases. Phase one investigate the effect of the crude extract while phase two 
investigates the effect of various solvents extracts from the crude extract. For the first phase, Thirty (25) albino 
rats were placed into six groups of five rats each. Extract was administered to animals for a period of two weeks  
Group I: Normal control 
Group II: hyperlipidemic control 
Group III: hyperlipidemic, administered with crude extract (E1) at a dose of 250 mg/kg. 
Group IV: hyperlipidemic, administered with crude extract (E1) at a dose of 350 mg/kg.  
Group V: hyperlipidemic, administered with crude extract (E1) at a dose of 450 mg/kg. 
At the end of experimental period the animals were euthanized. The blood of each rat was collected into a 
labelled centrifuge tube and centrifuged to obtain serum for lipid profile analysis. 
For the second phase, Thirty five (30) rats were grouped into six (6) groups of five (5) rats each. Extracts was 
administered to the animals for a period of two weeks, hyperlipidemia was induced using the method describe 
previously for the crude extract. 
Group I: Normal control 
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Group II: hyperlipidemic control 
Group III: hyperlipidemic, administered with 250 mg/kg of hexane extract (E2) 
Group IV: hyperlipidemic, administered with 250 mg/kg of chloroform extract (E3) 
Group V: hyperlipidemic, administered with 250 mg/kg of ethyl acetate extract (E4) 
Group VI: hyperlipidemic, administered with 250 mg/kg of residue after ethyl acetate extraction (E5) 
At the end of experimental period, the animals were euthanized. The blood of each rat was collected into a 
labelled centrifuge tube after which it was centrifuged and the serum obtained for analysis of lipid profile. 
 
2.6 Estimation of Parameters 
Serum HDL and LDL-Cholesterol were assayed by the method of Friedwald et al (1972), Triglycerides and 
Total Cholesterol by the method of Trinder (1969). The Artherogenic indices were estimated using lipid profile 
parameters as described below:   
I- Cardio Risk Ratio (CRR) = TCh / HDL-C (Martirosyan et al., 2007). 
II- Artherogenic Coefficient (AC) = (TCh – HDL-C)/ HDL-C (Brehm et al., 2004).  
III- Artherogenic Index of Plasma (AIP) = log (TG / HDL-C) (Dobiasova et al., 2001). 
 
2.7 Statistical Analysis 
Results were expressed as mean ± standard deviation and analyzed using ANOVA, with p value <0.05 
considered significant followed by Tukeyʹs post hoc test. A component of GraphPad Instat3 Software version 
3.05 by GraphPadInc was used to analyze the data (GraphPad, 2000). 
 
3. Results  
Table 1a shows the percent yield and total yield of Khaya senegalensis aqueous methanol extract (crude extract) 
while Table 1b shows the Percent yield and total yield from sequential extraction of the crude extract using 
solvents of increasing polarity.  
Table 1a: Percent yield and total yield of Khaya senegalensis aqueous methanol extract 
Plant Yield (%) Total yield (g) 
Aqueous methanol extract 10.91 54.55 
 
Table 1b: Percent yield and total yield of sequential extraction of the aqueous methanol extract of Khaya 
senegalensis stem bark using solvents of increasing polarity 
Solvents Yield (%) Total yield (g) 
Hexane 6.65 3.325 
Chloroform 2.91 1.455 
Ethyl acetate 10.82 5.41 
Residue 79.62 39.81 
Table 2 presents the body weight in gram of rats feed with normal grower mash (GI) and those feed 
with the high lipid diet (G II- G V). Body weight gain in rats feed with high lipid diet was significantly (p<0.05) 
higher than weight gain in normal control rats even at week four. At week six, significant increase in body weigh 
was observed at (p<0.01). While table 3 and 4 present the effect of administration of crude and solvents extract 
respectively.  
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Table 2: average weight gain of rats feed on standard feed and high lipid diet for six weeks 
 
Results are presented as Mean ± standard deviation, (n=12). Value with the same superscripts in a row 
are significantly (P<0.05) different compared to each other. a, b,c and d: significantly different from initial 
weight. 
Table 3: Effect crude extract (E1) of Khaya senegalensis stem bark on body weight of hyperlipidemic rats after 
one and two weeks of extract administration. 
 
Results are presented as Mean ± standard deviation, (n=5). Value with the same superscripts in a 
column are significantly different compared to each other (P<0.05).  
Table 4: Effect of different solvents extract (E2, E3, E4 and E5) on body weight of hyperlipidemic rats after one 
and two weeks of extract administration. 
        Period 
Group 
Weight at start of 
administration 
Weight at one 
week 
Weight after 
two weeks 
G I 126.00 ± 7.21 131.67 ± 6.50 138.00 ± 5.29 
G II 220.00 ± 13.22 233.67 ± 12.74 a 248.67 ± 14.46 a 
G III 215.00 ± 5.00 229.00 ± 7.00 242.67 ± 6.42 
G IV 195.00 ± 15.00 211.00 ± 11.79 225.67 ± 12.01 
G V 196.00 ± 11.53 201.00 ± 9.00 a 205.67 ± 9.50 a 
G VI 216.33 ±5.68 231.00 ± 8.54 246.67 ± 11.06 
Results are presented as Mean ± standard deviation, (n=5). Value with the same superscripts in a column are 
significantly different compared to each other (P<0.05). 
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Table 5 present the effect of aqueous methanol stem bark extract of Khaya senegalensis (E1) on lipid 
profile (TC, TG, LDL-Chol and HDL-Chol) of hyperlipidemic rats after two weeks of extract administration. 
The result shows a significant increase (p<0.01) in serum Total Cholesterol, triglyceride and LDL-Cholesterol in 
hyperlipidemic control group compared to normal control. A non-dose dependent decrease (p<0.05) in total 
cholesterol, triglyceride and LDL-cholesterol was observed in all test groups (GIII, GIV and GV) compared to 
hyperlipidemic control. From the table, no significant difference (p<0.05) was observed in HDL-cholesterol 
between all groups. 
Table 5: Effect of crude aqueous-methanol stem bark extract (E1) of Khaya senegalensis on lipid profile (HDL-
C, LDL-C, TC and TG) of hyperlipidemic rats 
  parameters 
groups 
TC (mmol/L) TG(mmol/L) LDL (mmol/L) HDL (mmol/L) 
G I 3.71± 0.25a 1.46 ± 0.20a 2.00± 0.15a 0.90± 0.08 
G II 8.27± 0.79a,b,c,d 4.32 ± 0.43a,b 4.41± 0.37a,b,c,d 1.01± 0.07 
G III 4.72± 0.36b 2.23± 0.06b 1.92± 0.10b 1.02± 0.11 
G IV 4.75± 0.50c 2.24± 0.22c 1.81± 0.23c 1.14± 0.23 
G V 4.63± 0.47d 2.10± 0.10d 1.91± 0.16d 1.12± 0.24 
Results are presented as Mean ± standard deviation, (n=5). Value with the same superscripts in a 
column are significantly different compared to each other (P<0.05). a: significantly different from control group. 
b,c and d: significantly different from hyperlipidemic group. 
Table 6 present the effect of administration of solvents extract from crude aqueous methanol stem bark 
extract (E1) on lipid profile (TC, TG, LDL-Chol and HDL-Chol) of hyperlipidemic rats. A significant increase 
(p<0.01) was observed in serum Total Cholesterol, triglyceride and LDL-Cholesterol in hyperlipidemic control 
group compared to normal control. A significant decrease (p<0.01) in total cholesterol, triglyceride and LDL-
cholesterol was observed in in group V (ethyl acetate extract treated group) compared to hyperlipidemic control. 
A decrease (p<0.05) in triglyceride was also observed in group IV treated with chloroform extract compared to 
hyperlipidemic control group.   
Table 6: Effect of different solvents extract (E2, E3, E4 and E5) of Khaya senegalensis stem bark on lipid profile 
(TC, TG, LDL-C and HDL-C) of hyperlipidemic rats 
 Parameters 
Groups 
TC (mmol/L) TG(mmol/L) LDL (mmol/L) HDL (mmol/L) 
G I 3.75 ± 0.75 a 1.78 ± 0.23a 1.89± 0.22a 0.81± 0.17 
G II 8.08 ± 0.43 a,b 4.31 ±0.23a,b,c 4.63±0.56a,b 0.79± 0.10 
G III 6.46 ± 1.35 3.68± 0.72 4.53± 1.39 0.63± 0.13 
G IV 7.75 ± 0.40 3.00± 0.40b 3.18± 0.32 0.69± 0.10 
G V 3.43 ± 0.40b 1.82± 0.17c 1.45± 0.22b 1.03± 0.14 
G VI 7.91±0.24 3.19±0.46 2.92±0.12 0.65±0.05 
Results are presented as Mean ± standard deviation, (n=5). Value with the same superscripts in a column are 
significantly different compared to each other (P<0.05). a: significantly different from control group, b and c: 
significantly different from hyperlipidemic control. 
Table 7 shows the values of artherogenic indices (CRR, AC, and AIP) of rats administered with 
different doses of crude extract (E1). A significant increase in CRR and AC was observed in hyperlipidemic rats 
compared to control, on the other hand a significant decrease in CRR and AC was observed between 
hyperlipidemic control (G II) and test groups (G III, G IV and G V).  
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Table 7: Artherogenic indices of rats administered with different dosses of crude extract (E1) 
 Parameters 
 
Groups 
Cardio Risk Ratio 
(CRR) 
Artherogenic 
Coefficient (AC) 
Artherogenic Index of 
Plasma (AIP) 
G I 4.12± 0.31a 3.12±1.06a 0.61± 0.23 
G II 8.18± 1.12a,b,c,d 7.18±1.02a,b,c,d 0.92± 0.32 
G III 4.62± 0.36b 3.62±0.22b 0.66± 0.14 
G IV 4.16± 0.22c 3.16±1.17c 0.61± 0.16 
G V 4.13± 1.95d 3.13±0.95d 0.62± 0.29 
Results are presented as Mean ± standard deviation, (n=5). Values with the same superscripts in a 
column are significantly different compared to each other (P<0.05). a: significantly different from control group. 
b,c and d: significantly different from hyperlipidemic group. 
Table 8 shows the values of artherogenic indices (CRR, AC, and AIP) of rats administered with 
different solvents extract from crude extract (E2, E3, E4 and E5). A significant increase in CRR and AC was 
observed in hyperlipidemic control (G II) and test groups (G III, G IV and GVI) rats compared to control (G I), 
on the other hand a significant decrease in CRR and AC was observed between hyperlipidemic control (G II) and 
ethyl acetate extract administered group (G V). No significant difference was observed in the level of AIP 
between groups. 
Table 8: Artherogenic indices of rats administered with different solvents extract (E2, E3, E4 and E5) 
 Parameters 
 
Groups 
Cardio Risk Ratio 
(CRR) 
Artherogenic 
Coefficient (AC) 
Artherogenic Index of 
Plasma (AIP) 
G I 4.62± 0.44a,b,c,d 3.62 ± 0.34a,b,c,d 0.66 ± 0.28 
G II 10.22± 0.43a,e 9.22 ± 0.23a,e 1.00 ± 0.36 
G III 10.25 ± 0.10b 9.25 ± 0.93b 1.01 ± 0.41 
G IV 11.23 ± 0.40c 10.23 ± 0.30c 1.05 ± 0.36 
G V 3.33 ± 0.28e 2.33 ± 0.33e 0.52 ± 0.15 
G VI 12.16±0.48 d 11.60 ±0.45 d 1.08 ±0.31 
Results are presented as Mean ± standard deviation, (n=5). Value with the same superscripts in a 
column are significantly different compared to each other (P<0.05). a,b c and d significantly different from 
control group, e: significantly different from hyperlipidemic group. 
 
Fig 1: FTIR result showing absorbance of ethyl acetate solvent (E4) 
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Fig 2: FTIR result showing absorbance of the most potent ethyl acetate extract (E4) 
 
4. Discussion 
Body weight gain in hyperlipidemic control rats (Table 2) was significantly (p<0.01) higher than weight gain in 
normal control rats. This is an indication of successful induction of hyperlipidemia as a result of six weeks 
feeding on high lipid diet. Significant increase (p<0.01) in serum total cholesterol, triglyceride and LDL-
cholesterol of animals fed with high lipid diet was observed when compared to normal control (Table 3 and 4). 
This is because the intake of high lipid rich food have been positively related to hyperlipidemia and the risk of 
cardiovascular diseases (Ma et al., 1999). This finding was in line with the findings of Austin 2007 who 
lamented that hyperlipidemic condition is presented with elevated serum total cholesterol, low density 
lipoprotein (LDL), very low density lipoprotein (VLDL) cholesterol and reduced high density lipoprotein (HDL) 
and/or elevated hypertriglyceridemia. Treatment with different concentrations of crude extract E1 (Table 1) 
reduced weight gain in test groups (G III, G IV and G V) compared to hyperlipidemic control rats (G II). 
However, significant reduction in weight gain was only observed in in ethyl acetate extract treated group (G V) 
in the second phase of the research. Thus, this might be the reason why Khaya senegalensis is used traditionally 
by obese people to control weight, hence confirming earlier report of the use of Khaya senegalensis stem bark 
extract to regulate body weight gain (Muhammad and Alhassan, 2016). 
The effect of oral administration of varying doses of crude extract (E1) on hyperlipidemic rats was 
shown in table 5. A non-dose dependent anti hyperlipidemic effect was observed. The results for the effects on 
total cholesterol and triglycerides showed significant decrease in their concentrations in all tests groups treated 
with the extract for two weeks compared to normal control. Thus it may be suggested that the extract may have 
affected cholesterol biosynthesis which resulted to reduction in the level of cholesterol in the blood. The low 
density lippoprotein cholesterol (LDL-Ch.) values obtained like that of cholesterol decreased after two weeks of 
extract administration. These results are in agreement with the work of 27. Onu et al., 2013 who carried out work 
on the effect of aqueous stem bark extract of the plant serum lipid levels.  
Administration of the solvents extract from sequential fractionation of the crude extract for two weeks 
shows a significant decrease in serum total cholesterol, triglycerides and LDL-cholesterol only in the ethyl 
acetate extract treated group (G V), this suggest that the ethyl acetate extract has the highest efficacy and contain 
the compound(s) responsible for the hypolipidemic activity of the crude extract.  
Epidemiologic surveys have shown a continuous linear relationship between cholesterol levels and 
chronic heart disease events, this was supported by the decrease observed in atherogenic indices of test groups 
compared to hyperlipidemic control. A similar relationship probably exists relating cholesterol levels to risk of 
ischaemic stroke (Zhang et al., 2003). A series of trials has been performed to examine whether or not achieving 
lower levels of LDL-cholesterol translates to increased therapeutic benefit. One recent study have both 
demonstrated a benefit in lowering LDL-C to levels substantially below 2.0 mmol/L in high-risk patients. A 
similar conclusion has been reached by the National Cholesterol Education Program who suggested a target 
LDL-C of 70 mg/dL (1.8 mmol/L) was a very reasonable therapeutic option in very high-risk patients (Grundy et 
al., 2010).  
The atherogenic indices: Cardio Risk Ratio (CRR), Atherogenic Coefficient (AC) and Atherogenic 
Index of Plasma (AIP) were used to predict the development of Myocardial Infarction (MI) and Ischemic Heart 
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Disease (IHD). According to Grover et al., 1999, the ratio of LDL-C /HDL-C or TG/HDL-C is a best related 
predictor of future cardiovascular events, however, TG/HDL-C ratio was shown to be a more accurate predictor 
of chronic heart disease. The logarithamatically transformed ratio of TG /HDL-C correlated closely with the 
LDL-C particle size and could serve as an indicator of the artherogenic lipoprotein phenotype (Priya et al., 2011). 
The Artherogenic Index of plasma (AIP) defined as (TG/HDL-C), has recently been proposed as a 
marker of artherogenicity because it is increased in people at high risk for chronic heart disease and it is 
inversely related with LDL-C particles (Meng et al.,2004). 
In this research, a significant decrease in CRR and AC was observed between hyperlipidemic control 
(G II) and test groups (G III, G IV and G V) in the first phase while a significant decrease in CRR,  AC and AIP 
was observed between hyperlipidemic control (G II) and ethyl acetate extract administered group (G V).  
FTIR result of the most active ethyl acetate extract revealed the presence of compounds containing 
carboxylic acids, alcohols and/or phenolic functional groups, with absorbance at 3376cm-1. The exact 
mechanism of action of this extract on lipid metabolism has not been clarified. One possible mechanism may be 
Khaya senegalensis lowers the plasma and hepatic cholesterol concentrations by suppressing/inhibiting HMG-
CoA reductase an enzyme that catalyzes the committed step in cholesterol synthesis (Stensvold et al., 1992). 
Although phenolics are not similar in structures to statins, they have been shown to inhibit HMG-CoA reductase 
activity both competitively with HMG-CoA and non-competitively with NADPH (Seenivasan et al., 2011). 
Another possible mechanism may be through counteracting LDL-cholesterol by promoting the reverse 
cholesterol transport pathway through inducing an efflux of excess accumulated cellular cholesterol (Assmann 
and Gotto, 2004). Also, TG lowering effect of the extract may contribute to inhibition of VLDL secretion by the 
liver and increase VLDL clearance via lipoprotein lipase pathway (Nelson and Cox 2005, Yokozawa et al., 
2006). 
 
5. Conclusion 
It can be concluded that stem bark extract of Khaya senegalensis shows good anti hyperlipidemic action against 
High lipid diet induced hyperlipidemia, with the ethyl acetate extract possessing the highest hypolipidemic 
activity. Hence, further studies that aim to isolate the active compound(s) and elucidating the possible 
mechanism of action(s) of the extract should be encouraged. 
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